Dual-target ligand discovery for Alzheimer’s disease: triphenylphosphoranylidene derivatives as inhibitors of acetylcholinesterase and $\beta$-amyloid aggregation | Mohamed Kandeel El-Ashrey

Dual-target ligand discovery for Alzheimer’s disease: triphenylphosphoranylidene derivatives as inhibitors of acetylcholinesterase and $\beta$-amyloid aggregation

Citation:: El-Hussieny, M., M. A. Abd-El-Maksoud, F. M. Soliman, M. A. Fouad, and M. K. El-Ashrey, "Dual-target ligand discovery for Alzheimer’s disease: triphenylphosphoranylidene derivatives as inhibitors of acetylcholinesterase and $\beta$-amyloid aggregation", Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 38, no. 1: Taylor & Francis, pp. 2166040, 2023.

Abstract:

n/a

Notes:

n/a